COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth.

Andreas RennerKatharina MarthKarin PatockaMarco IdzkoWolfgang Pohl

Published in: ERJ open research (2020)

Experience with very mild #COVID19 disease courses in two severe eosinophilic asthmatics with complete eosinophil depletion due to benralizumab treatment counters the recent theories that eosinophilia is protective in COVID-19 infections https://bit.ly/3cnEFvg.

Keyphrases

coronavirus disease
sars cov
early onset
chronic rhinosinusitis